Breast Cancer Subtype Classification Using Multi-omics Data Integration Based on Neural Network

2020 ◽  
Vol 47 (9) ◽  
pp. 835-841
Author(s):  
Joungmin Choi ◽  
Jiyoung Lee ◽  
Jieun Kim ◽  
Jihyun Kim ◽  
Heejoon Chae
2021 ◽  
Author(s):  
Kevin Chappell ◽  
Kanishka Manna ◽  
Charity L. Washam ◽  
Stefan Graw ◽  
Duah Alkam ◽  
...  

Multi-omics data integration of triple negative breast cancer (TNBC) provides insight into biological pathways.


2016 ◽  
Vol 14 (05) ◽  
pp. 1644002 ◽  
Author(s):  
Jinwoo Park ◽  
Benjamin Hur ◽  
Sungmin Rhee ◽  
Sangsoo Lim ◽  
Min-Su Kim ◽  
...  

A breast cancer subtype classification scheme, PAM50, based on genetic information is widely accepted for clinical applications. On the other hands, experimental cancer biology studies have been successful in revealing the mechanisms of breast cancer and now the hallmarks of cancer have been determined to explain the core mechanisms of tumorigenesis. Thus, it is important to understand how the breast cancer subtypes are related to the cancer core mechanisms, but multiple studies are yet to address the hallmarks of breast cancer subtypes. Therefore, a new approach that can explain the differences among breast cancer subtypes in terms of cancer hallmarks is needed. We developed an information theoretic sub-network mining algorithm, differentially expressed sub-network and pathway analysis (DeSPA), that retrieves tumor-related genes by mining a gene regulatory network (GRN) of transcription factors and miRNAs. With extensive experiments of the cancer genome atlas (TCGA) breast cancer sequencing data, we showed that our approach was able to select genes that belong to cancer core pathways such as DNA replication, cell cycle, p53 pathways while keeping the accuracy of breast cancer subtype classification comparable to that of PAM50. In addition, our method produces a regulatory network of TF, miRNA, and their target genes that distinguish breast cancer subtypes, which is confirmed by experimental studies in the literature.


2019 ◽  
Author(s):  
Sara Ravaioli ◽  
Francesca Pirini ◽  
Andrea Rocca ◽  
Maurizio Puccetti ◽  
Massimiliano Bonafè ◽  
...  

Author(s):  
Andrea Rocca ◽  
Sara Ravaioli ◽  
Eugenio Fonzi ◽  
Iros Barozzi ◽  
Ylenia Perone ◽  
...  

Mathematics ◽  
2021 ◽  
Vol 9 (13) ◽  
pp. 1574
Author(s):  
Ala’a El-Nabawy ◽  
Nahla A. Belal ◽  
Nashwa El-Bendary

Automated diagnosis systems aim to reduce the cost of diagnosis while maintaining the same efficiency. Many methods have been used for breast cancer subtype classification. Some use single data source, while others integrate many data sources, the case that results in reduced computational performance as opposed to accuracy. Breast cancer data, especially biological data, is known for its imbalance, with lack of extensive amounts of histopathological images as biological data. Recent studies have shown that cascade Deep Forest ensemble model achieves a competitive classification accuracy compared with other alternatives, such as the general ensemble learning methods and the conventional deep neural networks (DNNs), especially for imbalanced training sets, through learning hyper-representations through using cascade ensemble decision trees. In this work, a cascade Deep Forest is employed to classify breast cancer subtypes, IntClust and Pam50, using multi-omics datasets and different configurations. The results obtained recorded an accuracy of 83.45% for 5 subtypes and 77.55% for 10 subtypes. The significance of this work is that it is shown that using gene expression data alone with the cascade Deep Forest classifier achieves comparable accuracy to other techniques with higher computational performance, where the time recorded is about 5 s for 10 subtypes, and 7 s for 5 subtypes.


Sign in / Sign up

Export Citation Format

Share Document